News

SORT BY YEAR
21 March, 2016

Ally Bridge Group (ABG) Completes Its Investment in TESARO, Inc. (TSRO)

HONG KONG, Mar. 21, 2016 /PRNewswire/ — Ally Bridge Group (“ABG”), a global healthcare-focused investment group, announced that it has completed an equity investment in TESARO, Inc. (NASDAQ: TSRO), an oncology-focused, commercial-stage biopharmaceutical company headquartered in Waltham, Massachusetts, USA. This investment was made as part of a private placement of 4.4 million shares of TSRO common stock that closed on March 17, 2016, resulting in gross proceeds of $155 million.

RETURN TO NEWS